Neurocrine Biosciences reported $58.6M in EBITDA for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Acadia Pharmaceuticals ACAD:US $ -33.14M 79.36M
Acorda Therapeutics ACOR:US $ -6.2M 1.23M
Agios Pharmaceuticals AGIO:US $ -95.35M 3.32M
ALKERMES ALKS:US $ -15.07M 7.68M
Alnylam Pharmaceuticals ALNY:US $ -181.59M 44.32M
Amgen AMGN:US $ 3004M 337M
Aptinyx Inc APTX:US $ -17005000 2.27M
Biogen BIIB:US $ 1075.7M 401M
Biomarin Pharmaceutical BMRN:US $ 64.42M 7.75M
Cytokinetics CYTK:US $ -9.47M 67.05M
Dynavax Technologies DVAX:US $ 128.77M 96.32M
Enanta Pharmaceuticals ENTA:US $ -31.82M 1.2M
Exelixis EXEL:US $ 88.48M 0.75M
Gilead Sciences GILD:US $ 2585M 837M
Halozyme Therapeutics HALO:US $ 46.61M 29.84M
Intercept Pharmaceuticals ICPT:US $ -10.87M 0.98M
Intra Cellular Therapies ITCI:US $ -87.75M 15.26M
IONIS PHARMACEUT IONS:US $ -81.13M 27.92M
Nektar Therapeutics NKTR:US $ -44.27M 67.08M
Neurocrine Biosciences NBIX:US $ 58.6M 52.2M
Pfizer PFE:US $ 12921M 1739M
Prothena PRTA:US -43009000 5.26M
Regeneron Pharmaceuticals REGN:US $ 1381.3M 20.4M
Repligen RGEN:US $ 71.08M 1.53M
Sarepta Therapeutics SRPT:US $ -201.24M 125.08M
Teva Pharmaceutical TEVA:IT 1.09B 20M
Ultragenyx Pharmaceutical RARE:US $ -137.11M 4.57M
Vertex Pharmaceuticals VRTX:US $ 1156.6M 87.3M
Xoma XOMA:US $ -4766000 2.7M
YTE INCY:US $ 276.8M 132.69M